Clinical Trials Logo

Clinical Trial Summary

A comparative, observational, cross-sectional and prolective diagnostic test study, including patients that have had a right heart catheterization and were referred for a CT pulmonary angiography as part of their imaging workup protocol for pulmonary hypertension.

Dual-energy computed tomography (DECT) pulmonary angiography was performed on each patient to obtain perfusion maps and do a quantitative analysis. Segments with and without perfusion defects according to significant differences in the quantitative values, were defined as compatible or not with chronic thromboembolism.

To assess the accuracy of the method and evaluate its performance, these results were compared with the sole results from the right heart catheterization, known to be the gold standard diagnostic tool.


Clinical Trial Description

a comparative, observational, cross-sectional and prolective diagnostic test study is conducted, including consecutive patients from the pulmonary hypertension clinic at our institution, from March 2017 to October 2018. Patients that have had a right heart catheterization and were referred for a CT pulmonary angiography as part of their imaging workup protocol. (The minimum sample size calculated is 26 patients).

DECT pulmonary angiography (256-slice and double-source CT scanner) was performed on each patient. Obtaining perfusion maps and doing a quantitative analysis by circular regions of interest (ROI) and iodine-related attenuation values (IRA) on each lung segment. Then, according to the finding in right heart catheterization, a comparison will be made between to groups: segments with and without perfusion defects, in order to find significant differences in the quantitative.

To assess the accuracy of the method and evaluate its performance, these results were later compared with the sole results from the right heart catheterization.

ROC curves were plotted to extract possible decision thresholds of the IRA values to classify perfusion as normal or deficient with this technique. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03450304
Study type Observational
Source Instituto Nacional de Cardiologia Ignacio Chavez
Contact Cesar Cristancho Rojas, physician
Phone +525566119048
Email cncr777@hotmail.com
Status Recruiting
Phase N/A
Start date September 1, 2017
Completion date December 1, 2018

See also
  Status Clinical Trial Phase
Recruiting NCT06348459 - Registry of Catheter Intervention in Pulmonary Embolism
Not yet recruiting NCT06232551 - Alerting Providers at Patient Hospital Discharge to Consider Prescribing Rivaroxaban to Reduce Venous Thromboembolism N/A
Completed NCT03426124 - An International Pulmonary Embolism Registry Using EKOS
Not yet recruiting NCT06415968 - Prevalence and Characteristics of Intimate Partner Violence Against Individuals Seeking Hematological Consultations
Completed NCT02396758 - Optimum Duration of Acoustic Pulse Thrombolysis Procedure in Acute Pulmonary Embolism Phase 4
Recruiting NCT06051032 - Compative Study of PE in Thrombosed AVF After Balloon Thrombectomy vs. Thromboaspiration. N/A
Recruiting NCT05098769 - A Predictive Tool for Predicting Adverse Outcomes in Acute Pulmonary Embolism Patients Using CTPA.
Enrolling by invitation NCT04855370 - Non-Invasive Measurement of Cardiac Output and Stroke Volume in PE N/A
Recruiting NCT05482269 - Adverse Outcome of Acute Pulmonary Embolism by Artificial Intelligence System Based on CT Pulmonary Angiography
Active, not recruiting NCT05481242 - An Observational Study About Adverse Outcomes in Acute Pulmonary Embolism Patients
Completed NCT04632641 - Suture Closure AFtEr VEIN Access for Cardiac Procedures (SAFE-VEIN) Trial N/A
Recruiting NCT03101384 - Influence of Diagnostic Errors on the Prognosis of Acute Pulmonary Embolism N/A
Completed NCT04374617 - Risk of Venous Thromboembolism in Critically Ill Patients With Severe COVID-19